{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:16:46Z","timestamp":1791037006361,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1038\/sj.ejhg.5200652","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T22:08:37Z","timestamp":1032386917000},"page":"424-430","source":"Crossref","is-referenced-by-count":44,"title":["BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients"],"prefix":"10.1038","volume":"9","author":[{"given":"Laura","family":"Sarantaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Vahteristo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitta","family":"Tamminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Unkila-Kallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Butzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Nevanlinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,7,2]]},"reference":[{"key":"BF5200652_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ajmg.1320560305","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT, the Breast Cancer Linkage Consortium . Breast and ovarian cancer incidence in BRCA1-mutation carriers Am J Hum Genet 1995 56: 265\u2013271","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 1998 62: 676\u2013689","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng0797-210","volume":"16","author":"D Easton","year":"1997","unstructured":"Easton D . Breast cancer genes\u2013what are the real risks? Nat Genet 1997 16: 210\u2013211","journal-title":"Nat Genet"},{"key":"BF5200652_CR4","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1086\/302853","volume":"66","author":"R Moslehi","year":"2000","unstructured":"Moslehi R, Chu W, Karlan B et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 2000 66: 1259\u20131272","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DE et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 2001 68: 700\u2013710","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ng1295-428","volume":"11","author":"SA Gayther","year":"1995","unstructured":"Gayther SA, Warren W, Mazoyer S et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation Nat Genet 1995 11: 428\u2013433","journal-title":"Nat Genet"},{"key":"BF5200652_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ng0197-103","volume":"15","author":"SA Gayther","year":"1997","unstructured":"Gayther SA, Mangion J, Russell P et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene Nat Genet 1997 15: 103\u2013105","journal-title":"Nat Genet"},{"key":"BF5200652_CR8","unstructured":"Breast Cancer Information Core database (BIC): http:\/\/www.nhgri.nih.gov\/Intramural_research\/Lab_transfer\/Bic\/"},{"key":"BF5200652_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S0959-8049(00)00110-6","volume":"36","author":"H Anton-Culver","year":"2000","unstructured":"Anton-Culver H, Cohen PF, Gildea ME, Ziogas A . Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer Eur J Cancer 2000 36: 1200\u20131208","journal-title":"Eur J Cancer"},{"key":"BF5200652_CR10","first-page":"2433","volume":"4","author":"A Berchuck","year":"1998","unstructured":"Berchuck A, Heron KA, Carney ME et al. Frequency of germline and somatic BRCA1 mutations in ovarian cancer Clin Cancer Res 1998 4: 2433\u20132437","journal-title":"Clin Cancer Res"},{"key":"BF5200652_CR11","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJM199704173361602","volume":"336","author":"JF Stratton","year":"1997","unstructured":"Stratton JF, Gayther SA, Russell P et al. Contribution of BRCA1 mutations to ovarian cancer N Engl J Med 1997 336: 1125\u20131130","journal-title":"N Engl J Med"},{"key":"BF5200652_CR12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/hmg\/8.5.889","volume":"8","author":"SA Janezic","year":"1999","unstructured":"Janezic SA, Ziogas A, Krumroy LM et al. Germline BRCA1 alterations in a population-based series of ovarian cancer cases Hum Mol Genet 1999 8: 889\u2013897","journal-title":"Hum Mol Genet"},{"key":"BF5200652_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1","volume":"86","author":"M van der Looij","year":"2000","unstructured":"van der Looij M, Szabo C, Besznyak I et al. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary Int J Cancer 2000 86: 737\u2013740","journal-title":"Int J Cancer"},{"key":"BF5200652_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","volume":"178","author":"SC Rubin","year":"1998","unstructured":"Rubin SC, Blackwood MA, Bandera C et al. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing Am J Obstet Gynecol 1998 178: 670\u2013677","journal-title":"Am J Obstet Gynecol"},{"key":"BF5200652_CR15","first-page":"3663","volume":"56","author":"G Johannesdottir","year":"1996","unstructured":"Johannesdottir G, Gudmundsson J, Bergthorsson JT et al. High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients Cancer Res 1996 56: 3663\u20133665","journal-title":"Cancer Res"},{"key":"BF5200652_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1034\/j.1399-0004.1999.550504.x","volume":"55","author":"PM Tonin","year":"1999","unstructured":"Tonin PM, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D . Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history Clin Genet 1999 55: 318\u2013324","journal-title":"Clin Genet"},{"key":"BF5200652_CR17","first-page":"2738","volume":"56","author":"H Takahashi","year":"1996","unstructured":"Takahashi H, Chiu HC, Bandera CA et al. Mutations of the BRCA2 gene in ovarian carcinomas Cancer Res 1996 56: 2738\u20132741","journal-title":"Cancer Res"},{"key":"BF5200652_CR18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1086\/301880","volume":"62","author":"P Huusko","year":"1998","unstructured":"Huusko P, P\u00e4\u00e4kk\u00f6nen K, Launonen V et al. Evidence of founder mutations in Finnish BRCA1 and BRCA2 families Am J Hum Genet 1998 62: 1544\u20131548","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR19","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/hmg\/6.13.2309","volume":"6","author":"P Vehmanen","year":"1997","unstructured":"Vehmanen P, Friedman LS, Eerola H et al. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes Hum Mol Genet 1997 6: 2309\u20132315","journal-title":"Hum Mol Genet"},{"key":"BF5200652_CR20","first-page":"1050","volume":"60","author":"P Vehmanen","year":"1997","unstructured":"Vehmanen P, Friedman LS, Eerola H et al. A low proportion of BRCA2 mutations in Finnish breast cancer families Am J Hum Genet 1997 60: 1050\u20131058","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.ejhg.5200529","volume":"8","author":"L Sarantaus","year":"2000","unstructured":"Sarantaus L, Huusko P, Eerola H et al. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland Eur J Hum Genet 2000 8: 757\u2013763","journal-title":"Eur J Hum Genet"},{"key":"BF5200652_CR22","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/jnci\/92.18.1529","volume":"92","author":"K Syrj\u00e4koski","year":"2000","unstructured":"Syrj\u00e4koski K, Vahteristo P, Eerola H et al. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients J Natl Cancer Inst 2000 92: 1529\u20131531","journal-title":"J Natl Cancer Inst"},{"key":"BF5200652_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1054\/bjoc.2000.1626","volume":"84","author":"P Vahteristo","year":"2001","unstructured":"Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H . A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families Br J Cancer 2001 84: 704\u2013708","journal-title":"Br J Cancer"},{"key":"BF5200652_CR24","first-page":"1284","volume":"57","author":"LS Friedman","year":"1995","unstructured":"Friedman LS, Szabo CI, Ostermeyer EA et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families Am J Hum Genet 1995 57: 1284\u20131297","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ng0695-208","volume":"10","author":"FB Hogervorst","year":"1995","unstructured":"Hogervorst FB, Cornelis RS, Bout M et al. Rapid detection of BRCA1 mutations by the protein truncation test Nat Genet 1995 10: 208\u2013212","journal-title":"Nat Genet"},{"key":"BF5200652_CR26","first-page":"1068","volume":"60","author":"S H\u00e5kansson","year":"1997","unstructured":"H\u00e5kansson S, Johannsson O, Johansson U et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer Am J Hum Genet 1997 60: 1068\u20131078","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ng1197-341","volume":"17","author":"A Petrij-Bosch","year":"1997","unstructured":"Petrij-Bosch A, Peelen T, van Vliet M et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients Nat Genet 1997 17: 341\u2013345","journal-title":"Nat Genet"},{"key":"BF5200652_CR28","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJM199611073351908","volume":"335","author":"SC Rubin","year":"1996","unstructured":"Rubin SC, Benjamin I, Behbakht K et al. Clinical and pathological features of ovarian cancer in women with germ- line mutations of BRCA1 N Engl J Med 1996 335: 1455\u20131456","journal-title":"N Engl J Med"},{"key":"BF5200652_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","volume":"16","author":"\u00d3T J\u00f3hannsson","year":"1998","unstructured":"J\u00f3hannsson \u00d3T, Ranstam J, Borg \u00c5, Olsson H . Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden J Clin Oncol 1998 16: 397\u2013404","journal-title":"J Clin Oncol"},{"key":"BF5200652_CR30","first-page":"868","volume":"59","author":"PD Pharoah","year":"1999","unstructured":"Pharoah PD, Easton DF, Stockton DL, Gayther S, Ponder BA, the United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group . Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer Cancer Res 1999 59: 868\u2013871","journal-title":"Cancer Res"},{"key":"BF5200652_CR31","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","volume":"283","author":"J Boyd","year":"2000","unstructured":"Boyd J, Sonoda Y, Federici MG et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer Jama 2000 283: 2260\u20132265","journal-title":"Jama"},{"key":"BF5200652_CR32","doi-asserted-by":"crossref","unstructured":"Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, Adopted on February 20, 1996 . J Clin Oncol 1996 14: 1730\u20131740","DOI":"10.1200\/JCO.1996.14.5.1730"},{"key":"BF5200652_CR33","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","volume":"336","author":"FJ Couch","year":"1997","unstructured":"Couch FJ, DeShano ML, Blackwood MA et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer N Engl J Med 1997 336: 1409\u20131415","journal-title":"N Engl J Med"},{"key":"BF5200652_CR34","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","volume":"16","author":"TS Frank","year":"1998","unstructured":"Frank TS, Manley SA, Olopade OI et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk J Clin Oncol 1998 16: 2417\u20132425","journal-title":"J Clin Oncol"},{"key":"BF5200652_CR35","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/sj.bjc.6690235","volume":"79","author":"MJ Ligtenberg","year":"1999","unstructured":"Ligtenberg MJ, Hogervorst FB, Willems HW et al. Characteristics of small breast and\/or ovarian cancer families with germline mutations in BRCA1 and BRCA2 Br J Cancer 1999 79: 1475\u20131478","journal-title":"Br J Cancer"},{"key":"BF5200652_CR36","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","volume":"278","author":"D Shattuck-Eidens","year":"1997","unstructured":"Shattuck-Eidens D, Oliphant A, McClure M et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing Jama 1997 278: 1242\u20131250","journal-title":"Jama"},{"key":"BF5200652_CR37","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/bjc.1997.304","volume":"75","author":"J Tapper","year":"1997","unstructured":"Tapper J, Butzow R, Wahlstr\u00f6m T, Sepp\u00e4l\u00e4 M, Knuutila S . Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas Br J Cancer 1997 75: 1782\u20131787","journal-title":"Br J Cancer"},{"key":"BF5200652_CR38","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1086\/302583","volume":"65","author":"SA Gayther","year":"1999","unstructured":"Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA . The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes Am J Hum Genet 1999 65: 1021\u20131029","journal-title":"Am J Hum Genet"},{"key":"BF5200652_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/1097-0215(20000701)87:1<110::AID-IJC16>3.0.CO;2-6","volume":"87","author":"S Sutcliffe","year":"2000","unstructured":"Sutcliffe S, Pharoah PD, Easton DF, Ponder BA . Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer Int J Cancer 2000 87: 110\u2013117","journal-title":"Int J Cancer"},{"key":"BF5200652_CR40","first-page":"801","volume":"36","author":"HT Lynch","year":"1999","unstructured":"Lynch HT, de la Chapelle A . Genetic susceptibility to non-polyposis colorectal cancer J Med Genet 1999 36: 801\u2013818","journal-title":"J Med Genet"},{"key":"BF5200652_CR41","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1126\/science.8484121","volume":"260","author":"LA Aaltonen","year":"1993","unstructured":"Aaltonen LA, Peltom\u00e4ki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer Science 1993 260: 812\u2013816","journal-title":"Science"},{"key":"BF5200652_CR42","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 1998 58: 5248\u20135257","journal-title":"Cancer Res"},{"key":"BF5200652_CR43","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/labinvest.3780260","volume":"81","author":"H Lassus","year":"2001","unstructured":"Lassus H, Laitinen MPE, Anttonen M et al. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4 Lab Invest; 2001 81: 517\u2013526","journal-title":"Lab Invest;"},{"key":"BF5200652_CR44","first-page":"8","volume":"84","author":"P Venesmaa","year":"1994","unstructured":"Venesmaa P . Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977\u20131990 Obstet Gynecol 1994 84: 8\u201311","journal-title":"Obstet Gynecol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/5200652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5200652","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/5200652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T01:26:37Z","timestamp":1684373197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/5200652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["BF5200652"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejhg.5200652","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}